Q32 Bio Inc.
QTTB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $91 | $0 | $0 |
| Gross Profit | $0 | -$91 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,555 | $5,161 | $7,124 | $10,545 |
| G&A Expenses | $0 | $4,010 | $5,104 | $3,981 |
| SG&A Expenses | $4,022 | $4,010 | $5,104 | $3,981 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$91 | $0 | $0 |
| Operating Expenses | $7,577 | $9,080 | $12,228 | $14,526 |
| Operating Income | -$7,577 | -$9,171 | -$12,228 | -$14,526 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $188 | -$318 | $1,197 | $358 |
| Pre-Tax Income | -$7,389 | -$9,489 | -$11,031 | -$14,168 |
| Tax Expense | $0 | $0 | $0 | $21 |
| Net Income | -$7,389 | -$9,489 | -$11,031 | -$14,189 |
| % Margin | – | – | – | – |
| EPS | -0.6 | -0.78 | -0.9 | -2.33 |
| % Growth | 23.1% | 13.3% | 61.4% | – |
| EPS Diluted | -0.6 | -0.78 | -0.9 | -1.16 |
| Weighted Avg Shares Out | 12,241 | 12,198 | 12,198 | 12,198 |
| Weighted Avg Shares Out Dil | 12,241 | 12,198 | 12,198 | 12,198 |
| Supplemental Information | – | – | – | – |
| Interest Income | $500 | $0 | $700 | $900 |
| Interest Expense | $300 | $300 | $300 | $0 |
| Depreciation & Amortization | $0 | $91 | $119 | $120 |
| EBITDA | -$7,089 | -$9,098 | -$10,612 | $6,709 |
| % Margin | – | – | – | – |